SPR Provides a Boost to Drug Discovery and Development
Surface plasmon resonance techniques show promise as the new standards of drug discovery, especially for treating cancer. In the realm of drug discovery, the hunt is ever on for new combinations of analytes and receptors. Respectively, these are the chemicals that may become useful new pharmaceuticals and the molecules that, once bound by an analyte, direct the cells to which they are attached to perform specific actions. Some receptors, dubbed agonists, spur the cell to do something; antagon...
BioPhotonics, February 2012